Here, based on previous studies showing that TRF2 is over-expressed in CRC [29, 32, 33] and it is a marker of poor prognosis in several tumor histotypes [45, 46], we assayed the predictive role of TRF2 on the outcome of CRC patients. Here, TERF2 is linked to colorectal carcinoma.